Evaluation of peritoneal transport and membrane status in peritoneal dialysis: focus on incident fast transporters

Am J Nephrol. 2007;27(1):84-91. doi: 10.1159/000099332. Epub 2007 Feb 6.

Abstract

Background/aim: The determinants of baseline fast solute transport are still unclear. We prospectively investigated the relationship of peritoneal solute transport with markers of inflammation, angiogenesis, and membrane status, with a focus on fast transporters.

Methods: Seventy-one incident peritoneal dialysis patients were assessed with baseline and annual peritoneal equilibration tests, using a 3.86% glucose dialysis solution. Residual renal function and markers of inflammation, including systemic and intraperitoneal interleukin-6 (IL-6), effluent cancer antigen 125 (CA-125), and vascular endothelial growth factor (VEGF) appearance rates (ARs), were investigated. The time course of the dialysate-to-plasma ratio of creatinine (D/P creatinine ratio) and its relationship with the biomarkers were investigated by a mixed linear model.

Results: Incident fast/fast average transporters had a similar age, diabetes prevalence, and serum and effluent IL-6 levels, but significantly higher levels of CA-125 and VEGF ARs than the slow/slow average group; the D/P creatinine ratio was not correlated with systemic IL-6, but was correlated with effluent CA-125 AR (r = 0.45, p < 0.0001) and VEGF AR (r = 0.52, p < 0.0001). The D/P creatinine ratio decreased with a U-shaped profile (p = 0.02). Intraperitoneal IL-6 was the significant and positive determinant of the time course of the D/P creatinine ratio (p < 0.0001). Effluent CA-125 decreased with time on peritoneal dialysis (p = 0.013).

Conclusions: Baseline peritoneal fast transport was not associated with systemic inflammation, but was related to peritoneal locally produced substances able to mediate transitory hyperpermeability. The D/P creatinine ratio changed during the follow-up period with a U-shaped profile. This was associated with effluent IL-6 and partly with VEGF. CA-125 decreased throughout the follow-up period.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Ascitic Fluid / metabolism*
  • Biological Transport, Active / physiology
  • Biomarkers / metabolism
  • CA-125 Antigen / metabolism
  • Dialysis Solutions / pharmacokinetics*
  • Follow-Up Studies
  • Humans
  • Interleukin-6 / metabolism
  • Kidney Failure, Chronic / metabolism
  • Kidney Failure, Chronic / therapy
  • Membranes, Artificial*
  • Middle Aged
  • Peritoneal Dialysis, Continuous Ambulatory / adverse effects
  • Peritoneal Dialysis, Continuous Ambulatory / instrumentation*
  • Peritoneum / drug effects
  • Peritoneum / metabolism*
  • Peritonitis / etiology
  • Peritonitis / metabolism
  • Prognosis
  • Prospective Studies
  • Vascular Endothelial Growth Factor A / metabolism

Substances

  • Biomarkers
  • CA-125 Antigen
  • Dialysis Solutions
  • Interleukin-6
  • Membranes, Artificial
  • Vascular Endothelial Growth Factor A